Foghorn Therapeutics Inc. Quarterly Return On Assets in % from Q2 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Foghorn Therapeutics Inc. quarterly/annual Return On Assets history and growth rate from Q2 2021 to Q3 2024.
  • Foghorn Therapeutics Inc. Return On Assets for the quarter ending September 30, 2024 was -31 %, a 7.38% decline year-over-year.
  • Foghorn Therapeutics Inc. annual Return On Assets for 2023 was -30 %, a 22.9% decline from 2022.
  • Foghorn Therapeutics Inc. annual Return On Assets for 2022 was -24.4 %, a 31.1% increase from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -31 -2.13 -7.38% Jul 1, 2024 Sep 30, 2024
Q2 2024 -29.2 +0.33 +1.12% Apr 1, 2024 Jun 30, 2024
Q1 2024 -31.1 -4.18 -15.5% Jan 1, 2024 Mar 31, 2024
Q4 2023 -30 -5.6 -22.9% Oct 1, 2023 Dec 31, 2023
Q3 2023 -28.9 -5.86 -25.5% Jul 1, 2023 Sep 30, 2023
Q2 2023 -29.6 -3.04 -11.5% Apr 1, 2023 Jun 30, 2023
Q1 2023 -27 +3.06 +10.2% Jan 1, 2023 Mar 31, 2023
Q4 2022 -24.4 +11 +31.1% Oct 1, 2022 Dec 31, 2022
Q3 2022 -23 +19.3 +45.6% Jul 1, 2022 Sep 30, 2022
Q2 2022 -26.5 +14.2 +34.9% Apr 1, 2022 Jun 30, 2022
Q1 2022 -30 Jan 1, 2022 Mar 31, 2022
Q4 2021 -35.4 Oct 1, 2021 Dec 31, 2021
Q3 2021 -42.2 Jul 1, 2021 Sep 30, 2021
Q2 2021 -40.8 Apr 1, 2021 Jun 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.